1. Home
  2. CDZI vs PRQR Comparison

CDZI vs PRQR Comparison

Compare CDZI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDZI
  • PRQR
  • Stock Information
  • Founded
  • CDZI 1983
  • PRQR 2012
  • Country
  • CDZI United States
  • PRQR Netherlands
  • Employees
  • CDZI N/A
  • PRQR N/A
  • Industry
  • CDZI Water Supply
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDZI Utilities
  • PRQR Health Care
  • Exchange
  • CDZI Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • CDZI 257.9M
  • PRQR 232.8M
  • IPO Year
  • CDZI N/A
  • PRQR 2014
  • Fundamental
  • Price
  • CDZI $3.92
  • PRQR $2.19
  • Analyst Decision
  • CDZI
  • PRQR Strong Buy
  • Analyst Count
  • CDZI 0
  • PRQR 8
  • Target Price
  • CDZI N/A
  • PRQR $8.88
  • AVG Volume (30 Days)
  • CDZI 451.0K
  • PRQR 347.9K
  • Earning Date
  • CDZI 11-12-2025
  • PRQR 11-06-2025
  • Dividend Yield
  • CDZI N/A
  • PRQR N/A
  • EPS Growth
  • CDZI N/A
  • PRQR N/A
  • EPS
  • CDZI N/A
  • PRQR N/A
  • Revenue
  • CDZI $15,054,000.00
  • PRQR $20,129,184.00
  • Revenue This Year
  • CDZI $68.68
  • PRQR N/A
  • Revenue Next Year
  • CDZI $16.42
  • PRQR N/A
  • P/E Ratio
  • CDZI N/A
  • PRQR N/A
  • Revenue Growth
  • CDZI 460.46
  • PRQR 8.65
  • 52 Week Low
  • CDZI $2.13
  • PRQR $1.07
  • 52 Week High
  • CDZI $5.68
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • CDZI 66.80
  • PRQR 47.76
  • Support Level
  • CDZI $3.45
  • PRQR $2.21
  • Resistance Level
  • CDZI $3.82
  • PRQR $2.50
  • Average True Range (ATR)
  • CDZI 0.18
  • PRQR 0.14
  • MACD
  • CDZI 0.01
  • PRQR -0.01
  • Stochastic Oscillator
  • CDZI 93.46
  • PRQR 32.61

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: